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As the world population is increasing and societies become more technology driven, 
there is an imperative to develop ‘green energy’ sources to protect our planet. Cyanobacteria that 
have been genetically engineered to produce organic compounds that may be burnt as fuels show 
great potential, as they are an environmentally friendly and self-renewable, net carbon-neutral 
option. However, there are potential risks in the development and use of genetically modified 
organisms (GMOs). We need to understand in advance the risks that GMOs may pose to our 
environment and to animal and human health. This will enable experimental procedures, 
containment strategies and policies to be developed to prevent accidents and eliminate potential 
harmful effects of GMOs in the environment such as sharing antibiotic genes to native 
microorganisms. My research seeks to assess the bio-risk posed by engineered cyanobacteria and 
their capability of transferring genes of antibiotic resistance to other bacteria, they may encounter 
in their environment outside of laboratory conditions. Here genetically engineered (GE) 
cyanobacteria that contain antibiotic resistance genes commonly used as selective markers, are 
being studied and their ability to horizontally transfer to wild-type bacterial strains. In aim one, 
the plasmid vector that carries the transgenes to confer antibiotic resistance and to theoretically 
produce biofuel was introduced into the cyanobacteria, Thermosynechococcus elongatus BP1 
and select other gram-negative bacterial strains, Escherichia coli K12, Escherichia coli DH5α, 
 
and Pseudomonas putida KT2440, to assess their ability to carry the plasmid and obtain 
antibiotic resistance. In the second aim, the ability for the plasmid to undergo horizontal gene 
transfer (HGT), from GE cyanobacteria to two different strains of E. coli was determined. In the 
third aim, the ability of P. putida KT2440 to uptake the plasmid via HGT from GE cyanobacteria 
was studied. This research also examines the fundamental mechanisms of horizontal gene 
transfer, which is foundational to microbial life and not completely understood. The results 
reveal that HGT occurs between our model cyanobacteria and E. coli strains but not 
Pseudomonas. This research provides foundational knowledge to help develop policies and 
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Genetic Engineering with Synthetic Biology 
The recent advances in genetic engineering have made it a fascinating field to be working 
in today. Especially with the discovery and development of modern gene editing tools such as 
the gene editing CRISPR/ Cas9 system, for which Emmanuelle Charpentier and Jennifer Doudna 
were recently awarded the Nobel Prize,1 the possibilities for providing solutions to modern world 
problems through genetic engineering are seemingly endless.  Medicine, industry, and 
agriculture all stand to benefit from employing genetic editing techniques for solutions to 
problems. At the same time, as promising as gene editing may be, the implications of 
permanently altering an organism’s genome, both for the organism as well as its environment, 
remain unknown. Therefore, it is imperative that more research is done towards investigating this 
parameter. 
An area where genetic engineering techniques show great promise is in the modification 
of cyanobacteria to produce biofuel. This is due to their unique capability of utilizing inorganic 
carbon --in the form of CO2-- from their environment to produce organic products, with fast 
doubling times, while requiring little maintenance. This feature, combined with environmental 
concerns over the excess amounts of on CO2 currently found in the atmosphere, make genetically 
engineered (GE) cyanobacteria that have the ability to produce organic molecules to be used as 




GE Cyanobacteria for Biofuels 
Currently, 85% of the world energy demand relies on the consumption of fossil fuels2  It 
is to this day a profitable and expanding field that, according to the U.S. Energy Information 
Administration increased production by 12% from 2017 to 2018.3 However, it is a finite resource 
and the scenario of having to compete for diminishing oil reserves is a cause for great concern. 
For this reason, alternative fuel sources from natural, renewable reserves have been explored as 
options for being ultimately integrated in our daily lives. Examples of such renewable resources 
include solar, wind, hydroelectric and biomass energy. Of these, biomass is one that has the 
ability to make use of local energy supply, without the need of transportation. For this reason, it 
has been used in developing, non-industrialized countries to fuel local energy demand.4  
Biofuel is energy derived from biological sources. When considering its application and 
integration to the engines we use today, the ideal biofuel can be used without major engine 
modifications. To achieve this, biofuel has mostly been produced in the form of biodiesel or 
bioethanol, which require little modification to some the engines we already use.2 However, this 
is where the challenges of biofuel come into play. It is desirable to produce biofuel with certain 
characteristics so as to compete with the quality and energy produced from the combustion of 
fossil fuels. Bioethanol is a fossil fuel alternative that is largely produced from microbial 
fermentation of sugar or starch-rich plant, such as corn or sugarcane. When supplemented with 
gasoline, up to 85% (v/v) bioethanol can be used in engines without requiring modification to 
vehicles.5 Limitations arise from the need of arable land and water required for the plants used in 
the bioethanol production process to grow on. Proposed methods of making production of 
bioethanol more sustainable involve the addition of chemical pretreatment to aid with the 
decomposition of the plants’ biomass and water reutilization of the evaporators.6-8 However, the 
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fact that bioethanol has a low energy density makes essential the need to turn to other fuel 
alternatives. Longer carbon chains than the well-studied bioethanol make for higher biofuel 
quality, as C-C bonds have higher energy content. Furthermore, higher energy density allows for 
easier and more efficient energy transportation as more energy can be transported or stored at a 
given volume.9 For this reason, biofuel engineering has shifted towards the production of 
molecules with longer chain hydrocarbons.  
Around the world laboratories in both academia and industry are researching the 
production of high energy compounds for biofuel production. The main approach is genetic 
engineering of microorganisms. They do not require vast areas of land for their growth, have 
faster doubling times that plants, and their genomes are easier to manipulate. As with all major 
emerging fields, however, the ramifications to our environment, as well as animal and human 
health must be thoughtfully understood. This is the goal of USDA funded work, that has led to a 
collaborative project between Dr. Lee’s and Dr. Greene’s lab at Old Dominion University. A 
vital part of that project is evaluating the biosafety of the GE cyanobacteria with genes 
associated with biofuel production and antibiotic resistance. The engineered plasmid designed to 
be introduced into cyanobacteria includes a butanol dehydrogenase and a keto-acid 
decarboxylase gene intended to utilize the cyanobacteria’s intrinsic metabolic pathways to the 
production of biofuel and also includes genes conferring antibiotic resistance to the transformed 
cyanobacteria as selection markers in the cloning process. The pUC57 vector, that is used for the 
construction of the plasmid to be transformed into the cyanobacteria, carries a gene for 
ampicillin resistance, while the constructed cassette contains a gene conferring kanamycin 
resistance. Thus, the transformed cyanobacteria can be selected based on their ability to grow on 
media supplemented with antibiotics. Conferring onto the cyanobacteria tolerance to antibiotics 
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can potentially lead to health concerns when taking into account that if these GE cyanobacteria 
are released in the environment, they may pass these genes to other microorganisms that they 
encounter. The horizontal gene transfer (HGT) of these genes upon interaction of the GE 
cyanobacteria with other bacterial types is the focus of this thesis.  
 
Antibiotics 
Antibiotics are naturally secreted substances by bacteria in small amounts, constituting for 
1.6% among microbial products.10 The modern era of antibiotics began in 1929 with the first report 
on the discovery of penicillin by Alexander Fleming.11, 12 Synthetically made antibiotics have since 
been a standard method of treatment of bacterial infections. Penicillin proved to be effective in 
treating bacterial infections during World War II, yet it was not long before resistance to the 
antibiotic emerged. In fact, penicillin-resistant strains were already identified in the 1940s.13 Since 
then, antibiotic research and development has come a long way, yet widespread antibiotic 
resistance is still a problem with no lasting solution even today. Moreover, multiple drug resistant 
(MDR) strains have been identified, which pose a considerable threat as they create severe clinical 
problems. Years of increased and widespread overuse of antibiotics are eliminating the more 
susceptible strains, while selecting for the more tolerant ones. Hence, those that survive are the 
antibiotic resistant ones. When considering how to treat infections caused by strains with multi-
drug resistance, multiple drugs may be used.14  
Antibiotics are able to kill bacteria by targeting either their ability to reproduce, in which 
case they are called bacteriostatic, or their ability to produce necessary enzymes for their various 
functions and thus killing them, in which case they are called bactericidal. There are some that are 
considered broad spectrum antibiotics, more commonly used by doctors due to their effectiveness 
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against a wider range of bacteria. Below some of the different types of antibiotics relevant to my 
research are presented.  
 
Aminoglycosides 
Aminoglycosides are bactericidal and work by preventing bacteria to produce proteins that 
are essential for their function. Their basic structure consists of several aminated sugars bonded to 
a dibasic cyclitol (aminocyclitol) through a glycosidic bond.15 For many clinically relevant 
aminoglycosides that aminocyclitol is a 2-deoxystreptamnine (2-DOS) ring and is a characteristic 
structural feature.16, 17 Amino and hydroxyl substitutions to the core alter the molecule’s mode of 
action 18. Aminoglycosides act by binding to the ribosomes’ small ribosomal unit in the cell’s 
cytosol and impairing the bacteria’s ability to produce proteins.19 This causes misreadings or 
inhibition of translocation and thus interferes with the process of translation.17 The mistranslations 
result in a misfolded protein that, when inside the cell envelope, increases drug uptake and, in 
combination with the increased ribosome binding lead to cell death.20 Kanamycin belongs to this 
category.  
Tetracycline and its derivatives bind the 16S rRNA component of the 30S ribosome subunit 
and block access of aminoacyl tRNAs to the ribosome. They do not cause mistranslation but 
instead limit the bacteria to a stationary state of growth.20, 21 An interesting note is that even 
bacteriostatic antibiotics can cause cell death depending on the bacterial species or the treatment 
type. This has been found to be due to the sequence differences in the ribosomal proteins and 
RNAs.22 When used in high concentrations, it has been found that they are capable of binding to 
ribosomal units of mammalian cells as well, due to their lack of specificity in binding.23 
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Streptomycin was the first from this group of antibiotics to be used in 1944 and was derived 
from Streptomyces griseus. Waksman and his colleague, Schatz, received the Nobel prize for the 
discovery of this antibiotic and its antimicrobial properties against Mycobacterium tuberculosis. 
24, 25 It was subsequently produced and applied for treatment in medical cases of tuberculosis.26 In 
contrast to penicillin, which is effective against gram-positive bacteria, streptomycin is effective 
against a broad range of both gram-negative and gram-positive bacteria.27 Following streptomycin 
several other members of this class of antibiotics were isolated and synthesized, including 
neomycin, gentamycin, and kanamycin.18 
Due to aminoglycosides mode of action, they need to be found in the bacteria cell’s 
cytoplasm to be effective. Kanamycin A at physiological pH levels is triply protonated and can 
interact with the negatively charged bacterial membrane, increasing its disorder and contributing 
to the damaging effects against bacteria 16. Kanamycin and aminoglycosides in general are able to 
ultimately reach the cytoplasm of the cell through hydrophilic diffusion.28 Aminoglycosides have 
been found to be most effective against gram-negative bacteria instead of gram-positive.29  
 
β-lactams 
This class of antibiotics includes penicillin, cephalosporins and carbapenems. A key 
structural feature for these is the highly reactive β-lactam ring which contains 3 carbons and 1 
nitrogen.30 These antibiotics target the bacteria’s cell wall which is composed of peptidoglycan. 
The bacterial cell wall of gram-positive and gram-negative cells differs in composition, with the 
former’s consisting of more layers of peptidoglycan, resulting in a thicker cell wall, while the 
latter’s less layers, resulting in a thinner cell wall.31, 32 This antibiotic class’s mode of action is by 
covalently binding to penicillin binding proteins (PBPs), which are essential for hydrolyzing the 
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crosslinking of the peptidoglycan cell wall.30 The cell wall starts to break down, ultimately 
resulting in cell wall rupture.32 β-lactams are inhibited by β-lactamases, which are the main mode 
of antibiotic resistance against this class of antibiotics. Development of β-lactamase inhibitors to 
counteract the action of the β-lactamases has proven to restore the susceptibility to the antibiotic 
in some cases and make for a tool with great promise for combating MDR microbes.33, 34 
Ampicillin is a β-lactam, penicillin derivative that is active against gram-positive and gram-
negative bacteria. Ampicillin is the second antibiotic that is used in my research, as it is 
incorporated as a selection marker in the pUC57 plasmid vector being used as a building block for 
pKB. It is a broad-spectrum antibiotic and when used in combination to β-lactamase inhibitors, it 
has been known to be effective against MDR microbes by restoring their susceptibility to the 
antibiotics.34  
The spread of genes of ampicillin resistance has revealed some interesting discoveries. The 
genes associated with the production of β-lactamase, known as bla genes which are mostly 
responsible for ampicillin resistance, have been found to be associated with mobile genetic 
elements, such as plasmids, that are capable of being transferred across bacteria.35-38 Interestingly, 
in a study performed by Laskey and colleagues, investigating the capability of transfer of plasmid 
that carried genes of ampicillin resistance among three different bacterial strains in mice, it was 
found that it is possible from the gram negative E. coli to Salmonella as well as a different strain 
of E. coli.39 
 
Antibiotic Resistance  
The problem of widespread antibiotic resistance is a multi-faceted one, whose effects 
have a huge impact on society each year, with antibiotic resistant bacteria infecting more than 
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2.8 million people and causing 35,000 deaths annually.40  The emergence of antibiotic resistant 
microbes is predicted to have an even greater cost in human lives over the next years, with 
estimates predicting that within the next 30 years infections from antibiotic resistant microbes 
will cause the death of more than 10 million people annually, exceeding death even from cancer. 
40, 41 The strain and financial burden that antibiotic resistant infections put on both the healthcare 
system and individuals is great. At the same time, a decrease in innovation in antibiotic drug 
development has failed to produce novel antibiotics to keep up with the pace that microbes are 
developing resistance to treatments.42, 43 The challenge itself of producing an antimicrobial drug 
to which bacteria will not soon develop resistance, large development costs, and low approval 
rates have been a great demotivator for large pharmaceutical companies to be part of the 
antibiotic production pipeline.44   
To combat the issue of antibiotic resistant infections, a first very important step is to 
decrease and eliminate the overuse and abuse of antibiotics in healthcare and elsewhere. While 
over-prescription of antibiotics and incorrect consumption are a great part of the problem, 80% 
of the use of drugs in the United States is in agriculture.45, 46 Antibiotics are used to enhance the 
growth of livestock more so than to fight off dangerous diseases, a stark sign of overuse.45, 47, 48 It 
has been proven that overuse of antibiotics in agriculture also affects antibiotic resistance in 
clinical settings.49  
Six pathogens that are notorious for nosocomial infections that are especially hard to treat 
due to their high pathogenicity and resistance to multiple drugs, make up the acronym ESKAPE. 
These are: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter 
baumannii, Pseudomonas aeruginosa, and Enterobacter species.50 These are bacteria that have 
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high mortality rates.51 There are multiple ways these pathogens have been able to acquire 
antibiotic resistant genes.  
Aside from the development of resistance mechanisms to certain drugs, transfer of genes 
of antibiotic resistance from one strain to another is achieved through HGT. The various 
mechanisms of HGT such as plasmid conjugation, transduction via bacteriophage and 
transformation by uptake of naked extracellular DNA, allow for genes to be shared by means 
other than vertical transfer from parent to daughter cell.52 Especially in clinical settings, this has 
allowed for exchanges between P. putida with the pathogenic P. aeruginosa, the former of which 
has been characterized as a gene exchange platform, including for genes of antibiotic resistance, 
for the latter.53 Similar is the case for S. epidermis and the pathogenic S. aureus.54 These 
examples show how once antibiotic resistance is found in an environment, it is not only possible, 
but almost inevitable, for it to transfer between bacterial strains. Moving forward, it is vital that 
researchers, medical workers, policymakers, and those working in agriculture, coordinate 
towards the common goal of slowing antibiotic resistant infections caused by overuse of 
antibiotics in all fields and the development and implementation of new, more effective tools 
against them.   
 
Horizontal Gene Transfer 
Gene transfer is essential for the spread of antibiotic resistance among different bacterial 
strains. This is made possible through the  help of mobile elements such as plasmids.55  In contrast 
to vertical gene transfer, which is from parent to daughter cells, and achieved through replication 
(Figure 1A), HGT is achieved by transduction, carried through with the help of viral vectors, such 
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as bacteriophages, transformation and conjugation (Figure 1B). These represent the main 
mechanisms of horizontal or lateral gene transfer in bacteria. 
Bacterial conjugation is achieved by a pilus or adhesins between the two bacteria that 
facilitate the DNA transfer from the donor cell to the recipient.56, 57 This allows for the exchange 
of plasmid vectors that carry various genes. The drivers of this exchange may be environmental 
pressures. 58 In a study by Laskey and colleagues, it was demonstrated that only when the selective 
pressure of the mice being treated with ampicillin was present was there plasmid transfer from the 
strain that already was ampicillin resistant to recipient strains in the mice gut. In contrast, when 
the mice were not treated with ampicillin, there was no plasmid transfer observed as the only 
strains that were able to colonize the mice’s gut were those that already had the plasmid carrying 







Figure 1. Mechanisms of gene transfer between bacteria. (A) Vertical gene transfer refers to the 
gene transfer from parent cell to daughter cell. Changes in the genetic material occur in the form 
of mutations. (B) Horizontal gene transfer refers to gene transfer from a non-vertical gene transfer 
from a donor bacterial cell to a recipient cell. Two main forms of gene transfer are transformation, 
during which the recipient cell uptakes DNA from the environment after it has been released by 
the donor cell, and conjugation, during which donor-cell to recipient-cell contact facilitates transfer 




The exact molecular mechanism of conjugation is complex and requires coordination on 
multiple fronts, as elements from the cytoplasm of the cell are not only being transferred outside 
the cell, but the bacterial cell is paired to another one. A membrane-associated secretion system is 
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employed for the purpose of DNA transfer, known as type IV secretion system (T4SS) (Figure 
2).56 As part of this system, DNA mobilization genes are used to mobilize DNA that will be 
transferred, while mating pair formation genes code for proteins that will be part of the 
macromolecular structure of T4SS. DNA transfer replication genes are responsible for binding to 
DNA at the origin of replication (oriT) of the donor cell plasmid and form a structure called a 
relaxosome, which itself consists of several proteins. The complex of proteins that are part of the 
relaxosome are capable of acting as a helicase by nicking the plasmid to be transferred within the 





Figure 2. Schematic of T4SS. The protein complexes that are part of the pilus (VirB2 and VirB5), 
the core complex (VirB6-10), the inner membrane platform with the transmembrane domains of   
VirB3, VirB6, VirB8 and VirB10, and the ATPases VirB3, VirB6, and coupling protein VirD3. 
Created with Biorender.com and MS Word, based on data from the literature 56, 60  
 
 
Evolutionarily, T4SS has played an important role in contributing to the plasticity of 
bacterial genomes and allows them to acquire genes that grant lateral connections between 
bacterial lineages. There are multiple types of T4SS, whose variation in aspects such as gene 
content and order result in T4SSs with different component modules that are organized into a 
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single functional unit.61 It is noteworthy that these systems are capable of transferring both nucleic 
acids and, in certain cases, proteins from gram negative and positive bacteria to prokaryotic and 
eukaryotic recipient cells.62 Frequencies with which conjugation takes place among bacteria varies 
and differences in frequencies may be attributed to various factors. Generally, it has been found 
that decreased taxonomic relatedness between donor and recipient bacterial strains leads to 
decreased conjugation efficiencies.61, 63, 64 Furthermore, there are differences in T4SS systems in 
gram-negative and gram-positive microorganisms. While T4SSs in gram negative organisms have 
been well studied and characterized, with the most well studied being that of Agrobacterium 
tumefaciens, gram positive ones are less characterized. From the knowledge we have on gram-
positive conjugation so far, we know that it works better with self-transmissible or conjugative 
plasmids.65 These are plasmids that incorporate sequences for their MPFs and thus are mobilizable 
on their own.  
However, donor-recipient compatibility is not the only contributing factor to conjugation 
efficiencies. In experiments performed on mice, to investigate gene transfer through conjugation 
in the gut microbiota plasmids with different characteristics interfering with conjugation were 
used. Their conjugation efficiencies were measured using probed cells inside the gut microbiota. 
From this study, only one plasmid was able to be transferred to all probed cells, while the others 
has low or no transformation efficiencies.66 
Lastly, it is known that T4SS contributes to the pathogenicity of bacteria, either by allowing 
them to uptake genes that increase their pathogenicity, or as it was more recently shown to secrete 
toxin effectors into other bacteria resulting in their destruction.67 It was found that the plant 
pathogen Xanthomonas citri 68, 69 and human opportunistic pathogen Strenotrophomonas 
maltophilia  70 are capable of killing rival bacteria by secreting toxin effectors through T4SS 71. 
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In my thesis research, environmentally and clinically relevant strains were selected in order 
to investigate their interactions and HGT capabilities with those of the genetically engineered 
cyanobacteria, altered with the aim of producing biofuel. By investigating the presence of designer 
genes that were originally transformed into cyanobacteria in bacteria that they were in co-culture 
with, we are able to understand where HGT has occurred. We do this by employing genes 
conferring antibiotic resistance, which grant the bacteria that have uptaken them the ability to grow 
on media supplemented with antibiotics –kanamycin (40 μg/mL) or ampicillin (100 μg/mL).  
 
Bacterial Strains 
Thermosynechoccus Elongatus BP1  
 The genome of this bacteria was sequenced entirely in 2002 by Yasukazu et. al and it was 
found to be 2,593,857 base pairs long with no plasmid detected. It is a thermophilic bacterium that 
ideally lives in temperatures ranging from 45˚C to 55˚C and was originally isolated from hot 
springs in Japan.72 Under the microscope it appears rod-shaped. As a photosynthetic 
microorganism, T. elongatus BP1 has the ability to uptake inorganic carbon from the atmosphere, 
yet it has also been found to be capable of assimilating organic carbon that was supplemented in 
the media.73 The doubling time of this bacterium is 7-12 hours depending on how close to its ideal 
temperature it is being grown.74, 75 
 
Escherichia coli 
E. coli is a very well characterized bacterium, whose early success in first cloning 
experiments have made it the bacterium of choice for molecular cloning and continues to be used 
even today. It is a gram-negative, rod shaped bacterium, with a duplication time of 
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approximately 20 minutes. There are both pathogenic and non-pathogenic E. coli strains. Less 
than 1% of human gut bacteria constitute of E. coli or E. coli related bacteria, as they maintain a 
symbiotic relationship with the host organism by producing vitamin K12 as well as preventing 
gut colonization by pathogenic bacteria.76, 77  
There are hundreds of E. coli strains currently known and being used in research 
laboratories. They are all derivatives of two main wildtype strains the K12 and B strain.78 The 
derivatives of these strains that are commonly used in laboratory settings, such as the DH5α 
strain, have undergone various types of genetic modifications. The DH5α strain specifically has 
been modified to be negative for recA and endA genes. The endA gene codes for endonuclease I, 
which degrades double-stranded DNA, thus affecting the stability of the produced pDNA, while 
recA catalyzes DNA strand exchange reactions in ATP-dependent homologous recombination.79 
A mutation in its lac operon, lacZΔM15, makes it possible to perform blue-white screening of E. 
coli DH5α colonies to select for transformants when using plasmids such as pUC plasmids 
containing the lacZα sequence.80, 81 These modifications make E. coli DH5α ideal for use in 
cloning methods and plasmid amplification.  
  
Pseudomonas putida 
Pseudomonas putida KT2440 is a gram-negative type of bacteria that is commonly found 
in soil and water. It is an opportunistic pathogen in nosocomial settings but otherwise is rarely the 
cause of diseases, a characteristic that makes it safe for use in industry for synthetic processes, 
along with its metabolic robustness.82, 83 P. putida has the ability to degrade aromatic compounds 
found in its environment and can grow on such substrates, such as toluene and xylenes.84 For this 
reason, is also used in chemical synthetic processes, with rapid growth and high biomass yield.85 
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Specifically, P. putida KT2440 has been found to have high tolerance to heavy metals and 
metalloids, whose abundance is increased in the rhizosphere, which make this strain appealing for 
potential industry application.86 This has been characterized as an evolutionary trait that allows it 
to reside in depths of the soil where roots are found.  
P. putida KT2440 is rarely identified as the cause of disease in cases not associated with 
an immunocompromised state, with the first such case of bacteremia reported in 2013.82 P. putida’s 
relative, Pseudomonas aeruginosa is the pathogen lying behind most nosocomial infections of this 
strain.87 It is part of the group of pathogens collectively known and referred to as ESKAPE 
pathogens, which are commonly found in clinically acquired infections.88  In certain cases of 
hospital acquired infections, P. putida bacteria were found along with P. aeruginosa. Genetic 
studies of these bacteria lead to the conclusion that P. putida served as an exchange platform of 
antibiotic resistance genes for P. aeruginosa.53 This makes it especially dangerous for spread of 
antibiotic resistance in strains in hospitals and communities. In addition to their antibiotic 
resistance, both P. aeruginosa 89 and P. putida 83 are able to produce biofilm which enhances their 
ability to adhere on medical devices by forming clusters along with a self-produced adhesive 
matrix which includes polysaccharides, proteins and DNA.90 In hospital settings, biofilm 
formation allows these bacteria to contaminate surfaces and medical devices as well as develop 
antibiotic resistance.91  
 
Research Aims 
The overall aim of this thesis is to provide further insight into the bio-risk that genetically 
modified organisms (GMOs) pose for the transfer and spread of foreign genes into the 
environments that they are introduced. An assessment is conducted of GE cyanobacteria’s 
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capabilities to transfer genes of antibiotic resistance to bacterial strains they may encounter in their 
environment should they be found outside of contained laboratory conditions. The implications of 
this research are not only important for potential biofuel applications involving cyanobacteria, but 
for applications of GMOs in general. As we develop more sophisticated tools to manipulate 
genomes of microorganisms, their interaction with their environment and other bacteria is of 
particular interest from a biosafety perspective.  
In aim one, the plasmid carrying the designer genes for biofuel production and 
antibiotic resistance to ampicillin and kanamycin, is introduced to the cyanobacteria, T. 
elongatus BP1 and three gram-negative strains to assess their capacity of carrying the 
plasmid. The three gram-negative bacterial strains transformed and studied along with the T. 
elongatus BP1 cyanobacteria are: E. coli DH5α, E. coli K12, and P. putida. The success of the 
transformation and the ability of a strain to carry the plasmid is assessed from the ability of the 
transformants to grow on media supplemented with antibiotic, as antibiotic resistant genes were 
included in the plasmid construct as selective markers. The strains were selected based on different 
criteria. E. coli DH5α is a commonly used laboratory strain that is often used for molecular cloning 
procedures and thus studying it alongside the GE cyanobacteria would provide us information 
about the horizontal gene transfer process with recipient cells optimized for uptake of foreign 
DNA. E. coli K12 is the parent strain to E. coli DH5α and has not undergone genetic modifications 
to prime it for such processes, thus it is more of a wild-type E. coli strain. Lastly, P. putida is a 
soil bacterium that could be found in the same environment as the cyanobacteria should the latter 
escape laboratory containment and is also a relative of the pathogenic P. aeruginosa that is 
notorious for causing infections in clinical settings.  
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In the second aim we study the ability of the cyanobacteria to transfer plasmid 
encoded genes conferring antibiotic resistance to two model E. coli strains, E. coli K12 and 
E. coli DH5α, while in the third aim we study the capability of HGT from the cyanobacteria 
to P. putida KT2440. These two aims were designed to provide insight into the mechanisms of 
HGT and the fate of genes conferring antibiotic resistance between the model cyanobacteria and 
the three selected bacterial strains. By demonstrating that HGT is possible from GE cyanobacteria 
to these strains that may interact with outside of laboratory containment, it is possible to formulate 
containment strategies for large scale applications of GE cyanobacteria for biofuel production to 
effect escape and understand the ramifications should this occur.  
 
Experimental Methodology 
The schematic in Figure 3 portrays the combination and overlap of biochemistry, 
genetics, microbiology, and bioinformatics techniques used to develop my experimental strategy 
and to conduct the HGT experiments.  Once the constructed plasmid carrying genes aimed at 
biofuel production is transformed into cyanobacteria, the ability of it to be transferred to other 
types is assessed by growing them in co-culture with the GE cyanobacteria. The cells are then 
plated on selective media supplemented with antibiotics, to see if they have gained tolerance to 
it. If they have not, we may have a viable biofuel source safe to the environment and humans. 
However, if the bacteria gain antibiotic tolerance, they are a biohazard and containment methods 





Figure 3. Graphical representation of the HGT experimental strategy for biohazard assessment of 
GE cyanobacteria. It involved transforming the designer pUC-57 based plasmid vector into T. 
elongatus BP1. Co-cultures of GE T. elongatus BP1 with wildtype E. coli K12, E. coli DH5α, and 
P. putida were set up, and after plating on selective media, bacterial colonies were screened for 




The pKB DNA construct was designed using DNAstar bioinformatics software tools and 
synthesized in collaboration with GenScript.com.  The pKB DNA construct comprises PnirA - 
nirA promoter, KDC - keto-acid-decarboxylase, BDH - butanol dehydrogenase, PslpA - slpA 
promoter, KanR – kanamycin resistance gene, and Term-rubisco terminator. Up (RSI) and 
downstream (RSII) of the cassette are homologous recombination site sequences. Primers for 
PCR amplifications of certain genes of the plasmid and genes of the bacterial strains’ genome 
were designed using CLC Genomics Workbench v.12 software (Qiagen). Primers for 
distinguishing among the selected bacterial strains during experiments (Appendix A) and 




Polymerase Chain Reaction 
Polymerase chain reaction (PCR) is a common molecular biology technique that has 
recently gained much attention due to real time PCR (RT-PCR) being the method of choice for 
diagnosing patients with COVID-19.92 By creating multiple copies of a target DNA template, we 
are able to amplify that DNA fragment and detect it using gel electrophoresis. This is a technique 
based on the separation of DNA fragments by size within an agarose gel using an electric field. 
Each DNA fragment produced by PCR has a specific size which can then be detected on the gel 
and measured using a DNA ladder. 
 
Electroporation  
To introduce the plasmid DNA into the wildtype cyanobacteria and assess the bacteria’s ability 
to carry the plasmid, the pKB plasmid was transformed into these microorganisms using 
electroporation. The bacteria are inserted into a cuvette that is placed in to the electroporator 
(BIO-RAD, GenePulser Xcell). Optimized parameters for voltage, capacitance, and resistance 
for each bacterial strain are programmed into the electroporator to produce the appropriate pulse. 
The pulse allows for the plasmid to be inserted in the bacterial cells through pores formed as the 
pulse is discharged in the suspension where the cells and plasmid are present.93  
 
Cell cultures 
Co-cultures of the GE T. elongatus BP1 cyanobacteria along with E. coli K12, E. coli 
DH5α, and P. putida KT2440 were grown and cells were plated on selective media to determine 
which had taken up genes conferring antibiotic resistance. Monocultures of the different species 
are used for the appropriate control cultures.  
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Significance of Research 
The need for green energy and the focus on GMOs creates both possibilities and 
problems. The latter is the concern over the unintended consequences of using GMOs. This is 
especially crucial as the emergence of antibiotic resistant strains is a major health threat that we 
are currently facing. Widespread antibiotic resistance among strains that are commonly found in 
clinical settings are the cause of more than 2.8 million antibiotic resistant infections and more 
than 35,000 deaths in the US, as reported by the CDC 2019 report.94  The significance of this 
work lies in both the value of assessing the biohazard that GE cyanobacteria may pose when 
considered for biofuel production and the transfer capabilities of genes of antibiotic resistance to 















MATERIALS AND METHODS 
 
Strains and Culture Conditions 
T. elongatus BP1 is a photoautotrophic, thermophilic strain grown at 45˚C under constant 
light conditions under fluorescent lamps. The media used for the cyanobacteria in these studies 
were BG-11 and BG-110SA, the latter being a modified version of the former, as 4mM of 
(NH4)2SO4 is the nitrogen source instead of KNO3. This has been used as such by Thu et al. in 
studies using the same type of cyanobacterial transformants 95 and has been described 
previously.96 Additionally, the BG-110SA growth medium for the T. elongatus BP1 
transformants was supplemented with kanamycin (40 μg/mL). E. coli K12, E. coli DH5α, and P. 
putida KT2440 were grown in Luria Bertani (LB) medium at 37˚C. Transformed E. coli K12 and 
E. coli DH5α were grown in LB medium supplemented with either kanamycin (40 μg/mL) or 
ampicillin (100 μL/mL). P. putida 2440 transformants were grown in LB medium with 
kanamycin (40 μg/mL). 
 
Plasmids 
pKB plasmid  
The plasmid that was used in this research has been used to demonstrate HGT from 
transformed T. elongatus BP1 to E. coli DH5α.95 It is based on the pUC-57 plasmid vector, 
which carries genes of ampicillin resistance, and a pmb1 origin of replication (Figure 4). The 
designer genes, which aim to confer the ability to the cyanobacteria to produce butanol, keto-acid 
decarboxylase and butanol dehydrogenase, are found between two recombination sites, RSI and 
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RSII. They are preceded by an inducible promoter (nirA), which is induced by nitrate presence in 
the media 97, 98 and repressed by ammonium.99, 100 The KanR gene conferring kanamycin 
resistance is preceded by two continuous promoters, the promoter for the cpc gene from T. 
elongatus BP1 and the promoter for the slpA gene of Thermus thermophilus. Finally, the cassette 
contains a rubisco terminator. The total size of pKB is 9,007bp. 
 
 
Figure 4. Schematic of the pKB plasmid design. The plasmid was constructed to carry the 
annotated set of genes: PnirA - nirA promoter, KDC - keto-acid-decarboxylase, BDH - butanol 
dehydrogenase, PslpA - slpA promoter, KanR – kanamycin resistance gene, and Term-rubisco 
terminator. Up (RSI) and downstream (RSII) of the cassette are homologous recombination site 
sequences aimed at guiding the integration of the cassette, into the cyanobacteria’s genome. The 
origin of replication, oriT, and the ampicillin resistance gene, AmpR, are part of the pUC57 




A minimal plasmid, without the cassette carrying the alcohol producing genes, was 
transformed into the E. coli K12 and E. coli DH5a for comparison of the transformation results 
with those of electroporation with the pKB plasmid. pUC19 is related to pUC57, which is used 
for the construction of pKB, and contains the same ampicillin resistance gene and origin of 
replication.101-104 Its size is 2,686 bp. The pMB1 origin of replication ensures high copy 
numbers.105 pUC19 also contains a fragment from the N-terminal of the β-galactosidase gene, 
that is part of the well-characterized lac operon, and offers another selection system for pUC19 
transformants containing a lacZΔM15 mutation, such as E. coli DH5α Top10.80  
 
Genetic Transformation of pKB into T. elongatus BP1 
Wild-type T. elongatus BP1 cells were grown in liquid BG-110SA medium to reach 
OD730=20.0. They were pelleted down by centrifugation and resuspended in 400 μL of water. 
1μg of the pKB plasmid was added to the cell suspension. Electroporation was done at 5 kV/cm 
in a 2 mm cuvette using BioRad PowerPac Basic. A single pulse was provided for each 
transformation. Immediately after, the cells were transferred into flasks with 5mL of BG-110SA 
medium pre-warmed at 45˚C. The cells were then incubated overnight at 45˚C, under constant 
light conditions prior to being spread on agar BG-110SA medium supplemented with kanamycin 
(40 μg/mL). After 10-14 days of incubation at 45˚C and under constant light conditions, colonies 
of the transformed cells carrying the pKB with the kanamycin-resistance genes used as a 
selective marker appeared on the agar plates containing antibiotic. The colonies were streaked 
onto new plates and liquid cultures with BG-110SA medium with kanamycin (40 μg/mL) were 
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prepared as well, thus establishing a line of GE cyanobacteria to be used for the HGT 
experiments.  
 
Verification of Cassette in T. elongatus BP1 
Plasmid extraction was performed on the green colonies that grew on the BG-110SA 
plates with kanamycin (40μg/mL). PCR was performed to verify the presence of the pKB 
plasmid in the transformed cells. Two primers, Amp_fwd 
(TTACCAATGCTTAATCAGTGAGGCAC) and bdh0318_rev 
(CCTCCATTTCCTTTGCACCCT) were used, which were used to verify the plasmid as per 
Nguyen et al. with an expected band size of 4.5 kb.95  
 
Horizontal Gene Transfer Experiments 
Transformed T. elongatus BP1 cyanobacteria were grown in BG-110SA medium 
supplemented with kanamycin (40 μg/mL), at 45˚C, under constant illumination conditions, 
while their concentration was monitored by cell counting using a hemocytometer and an upright 
microscope (OLYMPUS LS). E. coli K12, E. coli DH5α, and P. putida K2440 overnight cultures 
were grown at 37˚C. Transformed T. elongatus BP1 cells were pelleted down by centrifugation, 
the supernatant was discarded, and the cells were suspended in fresh BG110SA medium without 
kanamycin to a final concentration of 107 cells/mL. 15 mL of the cyanobacterial suspension were 
then mixed with 15 mL of cells from each of the other strains, E. coli K12, E. coli DH5α, and P. 
putida KT2440 respectively, each at a concentration of 107 cells/mL to create the co-cultures. 
The resulting liquid co-cultures contained 15mL of LB medium and 15mL of BG-110SA for a 
total of 30mL. These co-cultures were incubated in a shaking incubator at 37˚C, under constant 
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light conditions provided by daylight fluorescent lamps. The controls for this experimental set-up 
were 30 mL cultures containing 15 mL of LB medium and 15 mL of BG-110SA medium with 
only one bacterial strain. Experiments were performed in triplicates. 
 
Control Studies 
Testing the Ability of E. coli DH5α, E. coli K12, and P. putida to Uptake DNA from the Media  
The ability of E. coli K12, E. coli DH5α, and P. putida KT2440 to uptake the pKB 
plasmid from their media was evaluated by setting up 30 mL liquid cultures containing 1:1 LB to 
BG-110SA ratio. Cell suspensions of E. coli K12, E. coli DH5α, and P. putida KT2440 at a 
concentration of 107 cells/mL each, in addition to the 1μg of the plasmid, were added to the 30 
mL liquid media. The cultures were incubated under constant light conditions and at 37˚C for 2 
days before being plated on selective media. This was a critical control experiment aimed to 
demonstrate that any HGT observed from co-cultures of the bacteria was not an artifact of the 
DNA uptake from the supernatant. 
 
Genetic Transformation of pKB into E. coli DH5α, E. coli K12, and P. putida KT2440  
To assess the ability of the different bacterial strains to carry the plasmid, the plasmid was 
initially transformed directly into the cells. Prior to the transformation, the cells were made 
competent using the following protocol. Cells from 10mL volumes of overnight cultures at a 
concentration of 109 cells/mL as determined by cell counting were centrifuged down to a pellet. 
The supernatant was discarded. Of particular importance was to discard the supernatant in its 
entirety even at the expense of a few cells, so that no arc would be detected during the pulsing step 
of the electroporation due to the salts of the culture growth medium. A mixture of 10% glycerol 
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was prepared using filtered glycerol and Millipore water. For each of the different types of bacteria, 
3 washes with 2mL, 1mL and 0.5mL of cold glycerol were performed respectively, centrifuging 
the cells for 3 minutes at maximum speed for each wash. During the washes, the cells were placed 




Figure 5. Transformation via electroporation. (A) Cells were made competent and suspended in 
10% glycerol. (B) The cell and plasmid suspension were placed inside a pre-chilled 2mm cuvette. 
(C) The electroporation parameters were set on the electroporator. (D) The time constant was 
recorded for each electroporation.  
 
 
Figure 5 shows snapshots of the process leading up to the pulsing of the bacteria for 
transformation of the plasmids. A 40-100μL volume of the electrocompetent cells was inserted in 
a microcentrifuge tube along with 0.5-1.0 μg of plasmid DNA and incubated on ice for 1minute. 
Plasmid DNA and cell mixture were transferred to pre-chilled 2mm cuvettes (Figure 5B) and were 
placed in the electroporation chamber of a Bio-Rad Gene Pulser Xcell microbial system that was 
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used for electroporation of the cells, following exponential decay protocols (Figure 5D). The cells 
were pulsed according to the parameters that were provided for each bacterial strain by the 
electroporator manufacturer, however, they were optimized for our cells to yield better 
transformation efficiencies. These parameters are summarized in Table 1. The cells were pulsed 
once and immediately transferred to a microcentrifuge tube with 1 mL of room temperature LB 
medium. The electroporated cells were incubated for 1 hr at 37℃, under shaking conditions of 150 
rpm, before being plated on selective media. Transformed E. coli K12 and E. coli DH5α were 
plated on LB agar, LB with Kanamycin (40 μg/mL) and LB with Ampicillin (100 μg/mL), while 
P. putida KT2440 was plated on LB and LB with Kanamycin only, as it is naturally resistant to 
the Ampicillin. The plates were incubated at 37˚C for the next 4 days. Colonies that were able to 
grow on antibiotic following electroporation typically appeared after 2-3 days and were then 
screened for the presence of transgenes from the plasmid using colony PCR. Experiments were 
performed in triplicates. 
 
 
Table 1. Summary of Electroporation Conditions for the Bacterial Strains 






T. elongatus BP1 2 1000 25 100 
E. coli K12 2 2500 25 200 
E. coli DH5α 2 2500 25 200 




PCR Analysis and DNA Sequencing  
To prepare the DNA for the colony PCR, with the tip of a cell spreader cells in a colony 
from the plate were put into 30 μL of Millipore water and incubated for 5 min. at 95℃. The mixture 
was then centrifuged for 3 minutes at maximum speed to collect cell debris on the bottom of the 
tube while keeping the DNA in the supernatant. For colony PCR, 2 μL of DNA template were used 
from these prepared samples. Apart from that, for the PCR mixtures for each of the samples, 10 
μL of Phusion high fidelity PCR master mix (Thermo Fisher Scientific) were used, along with 0.5 
μM of forward and reverse primers respectively, all of which add up to a total of 20μL of reaction 
mixture.  
The transfer of the genes from the GE cyanobacteria to the various bacterial strains was 
confirmed with the detection of the foreign genes in bacteria from the co-culture with the 
transformed T. elongatus BP1 using PCR and DNA sequencing. Amplification was achieved with 
the primers cpcPKan_fwd (TAATAGGCGTTTCCCTTCGTTGCC) to KanN_rev 
(CAAAATGGTATGCGTTTTGACACATCC). Sequencing of the PCR product of the amplified 
1kb kanamycin resistance gene was done by the Eastern Virginia Medical School Molecular Core. 








RESULTS AND DISCUSSION 
 
Transformation Experiments 
Transformation of T. Elongatus BP1  
Transformation of T. elongatus BP1 resulted in cyanobacteria transformants with the 
ability to express kanamycin resistance and grow on media supplemented with kanamycin (40 
μg/mL) (Figure 6A). Colonies were obtained from transformation via electroporation after 14 
days and were restreaked and grown in liquid media supplemented with kanamycin (40 μg/ mL) 
(Figure 6B). Amplifying a DNA region from plasmid extraction of the transformed 
cyanobacteria both part of the pUC57 vector and the cassette containing the genes aimed at the 
production of biofuel using primers Amp_fwd (TTACCAATGCTTAATCAGTGAGGCAC) and 
bdh038_rev (CCTCCATTTCCTTTGCACCCT), produced the results of Figure 6C. pKB is 
detected in sample 3 at 4.5 kb, at the same size as the positive control (Figure 6C). Primers 
cpcp_Kan_fwd (TAATAGGCGTTTCCCTTCGTTGCC) and KanN_rev 
(CAAAATGGTATGCGTTTTGACACATCC) were used to amplify the region containing the 
kanamycin resistance gene. The gene was detected at the expected band size of 1kb in Figure 





Figure 6. Transformation of pKB into T. elongatus BP1. (A) Colony growth on BG-110SA agar 
plate after 7 days of incubation under constant light conditions at 45˚C. (B) Cells were grown in 
liquid culture BG-110SA media supplemented with kanamycin 40 μg/mL. PCR on DNA from 
plasmid extraction from transformed T. elongatus BP1 using primers (C) cpcp_Kan_fwd and 
KanN_rev. and D. bdh_fwd and amp_rev. In panels C. and D., “M” denotes the molecular 
weight marker. pKB was used as the positive control, denoted with “+”, while WT T. elongatus 
BP1 were used as the negative control, denoted with “- “. Plasmid extracted from transformed T. 
elongatus BP1 is denoted with “P”.  
33 
 
Transformation of E. coli K12  
The results of the transformation of E. coli K12 are shown in figure 3. Following plating 
of the electroporated cells, no colonies were observed after 3 days of incubation on the plates 
containing antibiotic. Transformation was repeated 4 times, altering electroporation parameters 
with the same results. This was perplexing as, in contrast, the E. coli DH5α had growth of 
individual colonies on ampicillin, as is depicted in Figure 5A. Suspecting that the reason for the 
unsuccessful transformation of E. coli K12, the true wildtype E. coli strain is the size of the plasmid 
in a bacterial strain which, unlike E. coli DH5α is not primed for cloning procedures, a different 
plasmid was transformed into E. coli K12. pUC19 is a minimal plasmid, it contains no cassette 
with genes of antibiotic resistance, but contains the same ampicillin resistance gene as pUC57 that 
was used for the construction of pKB and the same pMB1 origin of replication (Figure 7B).101-103 
Therefore, by transforming E. coli K12 with pUC19, we were able to see that while pKB was not 
transformed and expressed in E. coli K12, a plasmid with similar characteristics but smaller in 
size, 2,686bp versus 9,007bp, was able to be successfully transformed into the bacteria. The plates 




Figure 7. Transformation of E. coli K12. (A) The agar plates onto which pulsed E. coli K12 cells 
were plated on after electroporation with pKB. Check marks indicate presence of growth, while 
x’s indicate no growth on the plate. (B) Schematic of the pUC19 plasmid vector. (C) The agar 
plates onto which pulsed E. coli K12 cells were plated after electroporation with pUC19 and 1 day 
incubation at 37˚C. 
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Transformation of E. coli DH5α 
There were 16 colony forming units (CFUs) that were counted on the ampicillin plates 
where pulsed E. coli DH5α were plated (Figure 8A). They were screened with primers 





Figure 8. Τransformation of pKB into E. coli DH5α. (A) The plates onto which pulsed E. coli 
DH5α was plated on. (B) PCR amplifying the region of the plasmid containing the origin of 
replication and the gene conferring ampicillin resistance. The band matches the expected size of 
1.6 kb. The lanes are denoted by: M (molecular weight marker), + (positive control), - (negative 
control), lanes 1-4 (DNA sample from transformed E. coli DH5α colonies.  
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This difference between the two strains is intriguing particularly because of the close 
relation between these two strains. Since the cells on the LB plate had grown to confluency after 
one day of incubation of the plates, the parameters chosen for electroporation of the bacteria were 
not lethal to them, otherwise there would be no growth observed. Having excluded the possibility 
that the voltage with which the bacteria were pulsed could have been too high and thus detrimental 
to them, other possible explanations are explored for why the E. coli K12 were unsuccessful in 
taking up the plasmid and expressing the genes that would allow them to grow on either agar plates 
with ampicillin or agar plates with kanamycin, when the same parameters were used for the E. coli 
DH5α and were successful in producing transformants. When considering the differences between 
the two strains, it is notable that DH5α is a K12 derivative whose mutations have been designed 
to give it an advantage in cloning procedures. With recA and endA mutations, E. coli DH5α is 
designed for maximum transformation efficiency as these mutations grant the bacteria the ability 
to uptake foreign DNA without making alterations to it that would affect its expression. Given the 
size of the plasmids used in these transformation experiments which are over 10kb, it is possible 
that E. coli K12 enzymes prevent the expression of the genes present in the plasmid, thus not 
allowing for kanamycin or ampicillin resistance. The recA protein participates in DNA repair and 
recombination.106 Bacterial strains that lack the endA1 mutation could destabilize any vector 
inserts that they are transformed with by general recombination taking place in the host.107 EndA 
codes for endonuclease I which cuts pure plasmid DNA.108 Thus, absence of mutations on these 
genes, allows for DNA degradation.  
What is more, as counted with the cell counter plugin of ImageJ,109 there were 16 CFUs of 
E. coli DH5α present on the plates that the transformants were plated on in this study. 150 μl of 
culture were plated on each agar plate. Given that the plasmid was extracted from E. coli DH5α to 
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begin with, the low amount of E. coli DH5α transformants obtained is less likely due to the strain’s 
inability to carry or express the plasmid. But rather the low efficiency of transformation obtained 
by the protocol followed to make the cells competent, which involved using washes of 10% 
glycerol while keeping the cells on ice. Either of these explanations or a combination of both could 
account for the differences in the results we see for the transformation with electroporation of E. 
coli K12 and E. coli DH5α.  
 
Transformation of P. putida KT2440  
It is known that P. putida KT2440 is capable of growing on ampicillin prior to 
undergoing transformation and for this reason the plating of this strain on selective media was 
done on agar with kanamycin. The results are shown in Figure 5. 91 CFUs were counted. Both 
the verification of the kanamycin resistance genes and the part of the vector containing the origin 
of replication and the ampicillin resistance were achieved with PCR using primers 
cpcp_Kan_fwd (TAATAGGCGTTTCCCTTCGTTGCC)with Kan_rev 
(CAAAATGGTATGCGTTTTGACACATCC), with a band size for all of the colonies screened 
at the expected size of 0.8kb and primers pmb1_fwd (CCCCCCTGACGAGCATCAC)with 
AmpR_rev (ATGAGTATTCAACATTTCCGTGTCG) with a band size corresponding to the 






Figure 9. Transformation of P. putida KT 2440. (A) Colonies were detected on the plates with 
kanamycin where P. putida was plated. Select clusters are circled to indicate their positions in 
various locations. The cells on the LB plate grew to 100% confluency. (B) Colony PCR amplifying 
the region of the plasmid containing the origin of replication, using the primers pmb1_fwd and 
AmpR_rev. The lanes in (B) and (C) are denoted by: M (molecular weight marker), + (positive 
control, the pKB plasmid), - (negative control, non-transformed P. putida), lanes 1-5 (DNA sample 
from transformed P. putida KT2440 colonies). (C) Colony PCR amplifying the region of the 
plasmid containing the kanamycin resistance genes, using primers cpcp_Kan_fwd and Kan_rev. 
The DNA sample from them that was used is from the same colonies that were screened in the 




 Together with the results of electroporating E. coli K12, E. coli DH5α, it is concluded that 
these bacterial strains are capable of carrying and replicating the pKB plasmid when transformed 
directly into them using electroporation. The low transformation rates are most likely due to the 
glycerol protocol followed to make the cells competent, as well as the size of the plasmid. To 
confirm the former, the pKB plasmid was transformed into competent E. coli Top10 cells. To 
confirm the latter, a control pUC 19 plasmid, with the same origin of replication as the pKB were 
transformed into the E. coli K12 and E. coli DH5α cells. pUC19 contains genes of ampicillin 
resistance so transformants of E. coli K12 and E. coli DH5α were able to grow on ampicillin plates.  
 
HGT Experiments 
 The flask setup for the HGT experiments is shown in Figure 7. Flasks with only one type 
of bacterial strain are used as controls for each type of bacteria used. Co-cultures of the 
transformed cyanobacteria along with each of the E. coli K12, E. coli DH5α, and the P. putida 
KT2440 were also set up. All flasks contained a 1:1 ratio of LB to BG-110SA medium that added 
up to a total of 30mL. Over the progression of the two days that these cultures were incubated at 





Figure 10. HGT experiments in liquid media. Flasks containing control monocultures, and co-
cultures with both the cyanobacteria and each of other bacteria (E. coli K12, E. coli DH5α, and 
P. putida KT2440) strained were monitored and plated over the course of two days. (A) 
Monoculture of GE T. elongatus BP1. (B) Monoculture of E. coli K12. (C) Co-culture of GE T. 
elongatus BP1 and E. coli K12. (D) Monoculture of E. coli DH5α E. Co-culture of GE T. 
elongatus BP1 and E. coli DH5α. (F) Monoculture of P. putida KT2440 G. Co-culture of GE T. 




It is observed that after day one the mono-culture and co-culture flasks containing E. coli 
K12, E. coli DH5α and the P. putida KT2440 monoculture obtain a cloudy appearance, and 
indication of bacterial cell growth. The mono-culture of GE T. elongatus BP1 and co-culture of 
the cyanobacteria with P. putida remain clear. The appearance of the cultures in the flasks is 
interesting to consider in correlation with cell counting data (Figure 11) that reveal that in the 
cloudier co-culture flasks there are more E. coli K12 (Figure 11A) and DH5α (Figure 11B) 
bacteria than the cyanobacteria. Conversely, in the cases when the co-cultures appear mostly 
clear, such as the P. putida and transformed BP1 co-culture in Figure 10G, cell counting revealed 





Figure 11. Bacteria growth curves for HGT experiments. Control monocultures of each cell type 
(orange), along with GE T. elongatus BP1 from monocultures (red) and co-cultures (yellow) are 
shown, while in blue is (A) Growth of E. coli K12 cells from co-cultures, (B) Growth of E. coli 




Figure 12. HGT experiments on plates using selective media. The check marks on the top right 
of each plate indicate that there was growth on the plate after 2 days incubation at 37 ˚C (with 
the exception of the BG-110-SA plates that took 7-10 days to present with growth) while the x’s 
indicate that there was not growth on the plate. Growth of E. coli K12, the co-culture with 
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Figure 12 (Continued). 
  
 
cyanobacteria and E. coli K12, E. coli DH5α, and the co-culture with cyanobacteria and E. coli 
DH5α was confluent on the LB plates. A-G labels indicate the culture flask from which cells 
were plated on each agar plate. A. Cells from the monoculture of GE T. elongatus BP1. (B) Cells 
from monoculture of E. coli K12. (C) Cells from co-culture of GE T. elongatus BP1 and E. coli 
K12. (D) Cells from monoculture of E. coli DH5α. (E) Cells from co-culture of GE T. elongatus 
BP1 and E. coli DH5α. (F) Cells from monoculture of P. putida KT2440 (G) Cells from co-
culture of GE T. elongatus BP1 and P. putida KT2440. Asterisks indicate plates are shown 
enlarged for more detail in Figure 12 (*) and Figure 13 (**).  
 
 
From Figure 12 it is observed that there was no growth on the LB agar or LB agar 
supplemented with kanamycin (40 μg/mL) or ampicillin (100 μg/mL). The E. coli K12, E. coli 
DH5α, and P. putida KT2440 cells from the control flasks with the monocultures were only able 
to grow on LB medium, with no antibiotic, whereas E. coli K12 and E. coli DH5α that had been 
in co-culture with the transformed T. elongatus BP1 were able to grow on LB agar with 
kanamycin (40 μg/mL). There were no colonies of E. coli K12 or E. coli DH5α detected on LB 
agar with ampicillin (100 μg/mL) from cells from their respective co-culture flasks with 
cyanobacteria. 
P. putida KT2440 grown in co-culture with the GE T. elongatus BP1 cyanobacteria did 
not grow as well as the P. putida KT2440 control, as indicated by their decreased numbers 
(Figure 11C) and the appearance of the co-culture flasks which remained clear even after 
incubation of 2 days (Figure 10G). In contrast, the control monoculture of P. putida KT2440 
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turned cloudy after day 1 and had increased P. putida growth. Lastly, the growth of P. putida 
KT2440 cells from the co-culture with the GE T. elongatus BP1 on the LB plates with no 
antibiotic was of individual colonies and not confluent as is the growth demonstrated by cells 
from the monoculture of P. putida KT2440 plated on LB agar medium.  
In addition, no colonies appeared on the LB plates with kanamycin (40 μg/mL) where 
cells from the P. putida KT2440 co-cultures with the cyanobacteria where plated (Figure 12G). 
The LB plate where cells from the co-cultures was plated did not present with confluent growth 
of P. putida KT2440 but individual pseudomonas colonies after 2 days of incubation. The cells 
from the control monoculture of P. putida KT2440 plated on the LB agar medium were 
confluent after two days of incubation of the plates at 37˚C. This could be an indication that the 
cyanobacteria or their metabolic products are toxic to the P. putida KT2440, resulting in the 
latter’s destruction when grown together in co-culture. P. putida KT2440 was not plated on LB 
agar with ampicillin because as it is naturally resistant to ampicillin, growth on that antibiotic 
would not necessarily be a sign of horizontal gene transfer from the GE cyanobacteria.  
The BG-110SA plates required more incubation time to exhibit colony growth of green T. 
elongatus colonies and were kept for more than 2 days to ensure the cells were able to grow 
(Figure 12). Green cyanobacterial growth appears on the BG-110SA plates from where cells from 
transformed T. elongatus BP1 control monoculture and the co-cultures were plated, after 7-10 
days of incubation.  
Colony PCR that was performed on selected E. coli K12 (Figure 13) and E. coli DH5α 
(Figure 14) colonies from the LB plates with kanamycin 40 μg/mL, confirmed the presence of 
the genes of kanamycin resistance that were part of the construct transformed into the GE 
cyanobacteria that the E. coli K12 and DH5α were in co-culture with. The bands present in lanes 
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with DNA from colonies 2, 5, and 6 for E. coli K12 (Figure 13) and 2, 4, 5, and 7 for E. coli 
DH5α colonies (Figure 14) are of the expected 1kb band size for the amplified kanamycin 
resistance genes. The primers used were cpcP_Kan_fwd 
(TAATAGGCGTTTCCCTTCGTTGCC)  and KanN_rev 








Figure 13. Confirmation of HGT from GE cyanobacteria to E. coli K12. (A) The LB plates with 
kanamycin 40 μg/mL onto which E. coli K12 colonies appeared, as indicated by the check 
marks. (B) A closer look at some of the E. coli K12 colonies on LB with kanamycin (40 μg/mL). 
(C) Colony PCR on the observed E. coli K12 colonies labeled 1-7, amplifying the kanamycin 
resistance gene, produced the expected band at 1kb for samples 2,5, and 6. “M” denotes the 
molecular weight marker, “+” indicates the positive control used (pKB), “- ” indicates the 




Figure 14. Confirmation of HGT from GE cyanobacteria to E. coli DH5α. (A) The LB plates 
with kanamycin 40 μg/mL onto which cells from co-culture of transformed T. elongatus BP1 and 
E. coli DH5α were plated and E. coli DH5α colonies appeared, as indicated by the check marks. 
(B) A closer look at some of the observed E. coli DH5α colonies on LB agar medium 
supplemented with kanamycin 40 μg/mL. (C) Colony PCR on the observed E. coli DH5α 
colonies labeled 1-7, amplifying the kanamycin resistance gene, using primer cpcp_Kan_fwd 
(TAATAGGCGTTTCCCTTCGTTGCC) and KanN_rev 
(CAAAATGGTATGCGTTTTGACACATCC), produced the expected band at 1kb for samples 
2,4,5, and 7.  “M” denotes the molecular weight marker, “+” is used to indicate the positive 
control used, which was the pKB plasmid, and “- ” indicates the negative control used, which 
was DNA from E. coli DH5α cells not grown in co-culture with GE cyanobacteria. 
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 To further validate the presence of the engineered construct in the colonies from the HGT 
experiments, overnight cultures from individual E. coli K12 and E. coli DH5α colonies that grew 
on LB agar medium supplemented with kanamycin (40 μg/mL) after incubation with the GE T. 
elongatus BP1 were grown, and plasmid was extracted from them. PCR was then run to confirm 
the presence of the gene conferring kanamycin resistance using primers cpcp_Kan_fwd 
(TAATAGGCGTTTCCCTTCGTTGCC) and KanN_rev 
(CAAAATGGTATGCGTTTTGACACATCC). The results (Figure 15) show that in 2 out of the 
3 samples from plasmid extraction from E. coli K-12 (lanes 1-3), and 3 out of the 3 samples from 




Figure 15. Confirmation of the presence of the engineered kanamycin resistance genes from 
plasmid extraction of E. coli K12 and E. coli DH5α. The expected bands appear at 1kb. “M” 
denotes the molecular weight marker; “+” denotes the positive control (PKB); “A-” denotes the 
E. coli K12 negative control; “B-” denotes E. coli DH5α negative control; lanes 1-3 contain 
DNA sample from plasmid extraction on E. coli K12; lanes 4-6 contain DNA sample from 
plasmid extraction on E. coli DH5α. 
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 These findings demonstrate that E. coli K12 and E. coli DH5α are able to grow in co-
culture with GE T. elongatus BP1 transformed with the pKB and uptake genes that allow it to be 
resistant to kanamycin and grow on LB agar supplemented kanamycin (40 μg/mL). Lastly, proof 
of HGT from the GE cyanobacteria to the E. coli K12 and E. coli DH5α strains are the 
sequencing results of the kanamycin resistance sequence from the transformed T. elongatus BP1 
and the E. coli cells that were able to obtain kanamycin resistance after growing in co-culture 
with the GE cyanobacteria. In Figure 15, the trace data from the sequenced kanamycin resistance 







Figure 16. Sequencing of kanamycin resistance gene from transformed T. elongatus BP1 (BP1-
120) and E. coli K12 and E. coli DH5α. In this figure, which includes trace date from 
sequencing, a 270 kb region that is part of the kanamycin resistance gene appears to be 




The capability of each of the bacterial strains used in the horizontal gene transfer 
experiments to be naturally transformed by the plasmid in liquid media were assessed. The liquid 
cultures in which the bacteria were incubated with the 1μg of plasmid were followed over the 
course of 2 days and each day cells from each culture flask were plated on selective media, 
containing either kanamycin (40 μg/mL) or ampicillin (100μg/mL), as pictured in Figure 11. P. 
putida KT2440 was not plated on LB agar supplemented with ampicillin (100μg/mL) as it is 
known that it is tolerant to it. With this setup, the conditions of the HGT experiments were 
closely mimicked to control for DNA uptake of these bacterial strains from the supernatant.  
The bacteria were incubated at 37˚C, with the same concentration of plasmid that the 
cyanobacteria are transformed with. Cells were plated on selective media to assess their 
capability of growing on media supplemented with antibiotics. E. coli K12 and E. coli DH5α 
were plated on agar media supplemented with kanamycin (40 μg/mL) as well as ampicillin (100 
μg/mL). After 2 days of incubation of the plates at 37˚C, the only growth observed was on the 
LB agar plates, where the cells grew to confluency (Figure 18).  No colonies appeared on the 
agar plates supplemented with antibiotics indicating that the cells incubated with the plasmid did 




Figure 17. Assessment of bacteria to uptake pKB from liquid media. Cells of each type of strain, 
at a concentration of 107 cells/mL, were incubated at 37˚C for 2 days, in 30mL of 1:1 LB to 




Figure 18. Plating of cells on selective media to assess natural transformation with pKB. (A) E. 
coli K12, (B) E. coli DH5α, and (C) P. putida KT2440 cells that were incubated with 1000ng of 
pKB were plated on selective media. The check marks on the top right of each plate indicate that 
there was growth observed, whereas the X’s indicates there was no growth observed.  
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This is not to suggest that these bacterial strains are not naturally transformable, as there 
are reports of natural transformation of E. coli for instance.110  However, natural transformation 
of E. coli K12, E. coli DH5α, and P. putida KT2440, specifically with pKB, was not observed 
when these experiments were performed in triplicates. Thus, this eliminates the possibility that 
the HGT observed is an artifact of uptake of naked DNA from the growth media. It is therefore 
concluded that the E. coli K12 colonies (Figure 12A) and E. coli DH5α (Figure 13A) colonies 
that grew on kanamycin (40 μg/mL) are a result of gene transfer from the GE T. elongatus BP1 

















CONCLUSIONS AND FUTURE WORK 
 
Curious Case of P. putida KT 2440 and T. elongatus BP1 
 In summary, this work suggests that HGT of genes conferring antibiotic resistance is 
possible from GE cyanobacteria to E. coli K12 and E. coli DH5α. The results for E. coli DH5α 
are consistent with those reported by Nguyen et. al.95 However, that is not the case with P. putida 
KT2440, in which case no HGT was observed. One factor that this could be due to is that 
expression of the plasmids with some of the same characteristics as pKB that was used here has 
been found to be unpredictable in P. putida KT2440.111 However, since with direct 
transformation into P. putida, the kanamycin resistant genes were able to be expressed, it could 
be a mechanism of HGT that is not activated in this case. The abnormal growth on the LB agar 
plate were P. putida KT2440 that had grown in co-culture with the GE cyanobacteria were 
plated, is a perplexing phenomenon, indicating that the P. putida KT2440 is not tolerating the 
cyanobacteria very well. It could be possible that metabolic products secreted by the GE T. 
elongatus BP1 are deleterious to the P. putida KT2440. To evaluate whether the GE 
cyanobacteria are responsible for excreting metabolic products in their media that prevent the 
normal growth of P. putida KT2440 the supernatant of the GE cyanobacteria could be used to 
culture Pseudomonas cells in while monitoring their growth.  
 The control experiment where the uptake of the pKB plasmid by the bacterial strains 
from the media is assessed, indicates that it is not possible to occur. This indicates that the HGT 
via conjugation that is observed is not an artifact of DNA uptake from the cells by the media. 
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Conjugation is a guided process that requires coordination of the donor cyanobacterial cells and 
the recipient E. coli cells in the cases where it is observed.  
We also observed that in cases when transformation via electroporation was possible, 
HGT was not observed and the opposite. For E. coli K12 in particular, while direct 
transformation via electroporation with the pKB plasmid was not successful, when grown in co-
culture with the transformed T. elongatus BP1 cyanobacteria, the cells were able to uptake the 
kanamycin resistance genes. It is reported that the transformation of E. coli K12 may be 
prevented by the DNase activity that other E. coli strains, such as E. coli DH5a do not present 
due to the genetic modification they carry.112 Therefore, HGT of the kanamycin resistance genes 
indicates that via conjugation E. coli K12 bacteria are able to uptake genes via conjugation that 
could not be directly transformed into them through electroporation. On the other hand, the 
Pseudomonas strain is a case where HGT is not observed, despite direct transformation of the 
pKB plasmid in the P. putida KT2440 cells having been verified.  
 
Limitations 
Limitations of this work arise from our inability to completely mimic environmental 
conditions that the cyanobacteria may be found in, having escaped laboratory containment. 
However, by lowering the temperature for the growth conditions, in the Percival they are grown 
at 45˚C whereas they are incubated at 37˚C for the HGT experiments and incubating them in 
media composition that is different from their preferred media we are testing their ability to 
survive and transfer genes to other bacterial strains under non-ideal conditions. This type of 
thermophilic bacterial strain is not capable of growing at temperatures below 30˚C, therefore 
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there is little concern for spreading genes of antibiotic resistance under those conditions. This 
way, the thermophilic quality of T. elongatus BP1 serves as a biohazard safeguard. 
 
Future Work 
 The results of this research make it imperative to design strict biohazard containment 
policies and experimental designs, not only when working with GE cyanobacteria that have been 
modified for biofuel production in general but for GMO applications and experiments in general. 
There should also be laboratory containment policies in place put forth by government agencies 
such as the USDA oversighting GMO research that safeguard against the escape of GE bacteria, 
as they may pose a threat to human health when genes of antibiotic resistance are part of the 
engineering process.  
HGT experiments from the E. coli K12 and DH5α cells that were able to uptake the 
kanamycin resistance gene from the GE T. elongatus BP1 cyanobacteria to other bacteria would 
reveal if secondary HGT events may be observed. Future work also involves the evaluation of 
the HGT capabilities of the genes conferring antibiotic resistance from the GE cyanobacteria to 
more bacterial strains. Specifically, gram-positive strains will be studied in order to acquire a 
deeper understanding of HGT towards different types of bacteria, as well as how these strains 
interact with the GE cyanobacteria. Gram-positive bacteria are composed of a thick 
peptidoglycan wall and their conjugation processes are different than gram-negative.113 
Preliminary experiments are underway with bacterial strains B. licheniformis ATCC 14580 and 
S. epidermis ATCC12228. Primers for the identification of the bacterial strains used in the lab 
have been designed (Appendix A). This research would shed more light on differences between 
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PRIMER DESIGN FOR IDENTIFICATION OF BACTERIA P. PUTIDA KT2440, S. 
EPIDERMIS ATCC 12228, AND B. LICHENIFORMIS ATCC14580 
 
With the introduction of more bacterial strains in the lab, it was fundamental to be able to 
distinguish between them using a genetic technique. Primers were designed for P. putida 
KT2440 that was used in the HGT experiments as well as Staphylococcus epidermis ATCC 
12228 and Bacillus licheniformis ATCC14580, that are intended for future experiments. Genes 
were selected based on the characterization previously done on them in the literature. For P. 
putida, primers were designed for the gyrase B gene, which in studies by Yamamoto and 
Harayama was amplified, sequenced and used for identification of P. putida against E. coli and 
Bacillus Subtilis.114 GyrB was selected as the gene to be amplified for the identification of S. 
epidermis, as it has been found in its more pathogenic S. aureus relative to be associated with 
resistance to antibiotics.115 For B. licheniformis the recF gene was selected that codes for the 
recF protein and has been characterized in its relative strain B. subtilis.116  
Each of the primer sets (forward and reverse for each bacterial strain) were run on DNA 
samples from all the bacterial strains used in the lab to ensure that they amplify the target genes 
only in the strains they are expected to positively identify. Thus, the primer for P. putida’s gyrB 
resulted in the band at 2.4 kb only for the sample containing DNA from P. putida KT2440, while 
it was negative for all other bacterial strains (Figure A1A).  Similarly, when the primers designed 
for S. epidermis’s gyrB and B. licheniformis’s recF genes, and run through DNA from all the 
other bacterial strains, they resulted in a 1.9 kb (Figure A1B) and a 1.1 kb (Figure A1C) band for 
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the identification of S. epidermis ATCC 12228 and B. licheniformis ATCC 14580 respectively. 
The off-target band in lane D of Figure A1C) is where the primers designed for B. licheniformis 
amplified a sequence from S. epidermis. However, because the band in lane D is at 1.2 kb based 
on the MW marker, these primers result in positive identification of B. licheniformis ATCC 
14580. These results show that the designed primers can be used for the positive identification of 
each of the bacterial strains. 
 
 
Table A1. Primers designed for bacteria strain identification  
Bacterial 
Strain 
P. putida KT2440 S. epidermis ATCC 12228 B. licheniformis ATCC 
14580 






























Figure A1. Identification of P. putida KT2440, S. epidermis and B. licheniformis with PCR. 
Primers designed for each strain in (A), (B), and (C) were run through DNA from all bacterial 
strains used in the lab (A-E): E. coli K12 (samples A), E. coli DH5α (samples B), P. putida 
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